Skip to main content

Advertisement

Table 1 Demographics, hemodynamic parameters and major laboratory values in non diabetics (NO DM) and diabetics (DM)

From: Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61

  No DM (N = 1661) DM (N = 373) p value
BMI 26.8 ± 4.1 28.8 ± 4.7 < 0.001
Sex    
 ♂ 1313 295 0.99
 ♀ 348 78  
% female 21.0% 20.9% 0.91
Age (years) 62.8 ± 12.4 66.5 ± 12.2 < 0.001
Hypertension 883 (53%) 291 (78%) < 0.001
Previous MI 198 (11.9%) 83 (22.2%) < 0.001
Previous PCI 244 (14.7%) 92 (24.7%) < 0.001
Previous CABG 62 (3.7%) 36 (9.7%) < 0.001
Previous stroke 29 (1.7%) 18 (4.8%) < 0.001
Previous TIA 18 (1.1%) 15 (4.0%) < 0.001
ACS type    
 STEMI 948 (57.1% 174 (46.7%) < 0.001
 NSTEMI 663 (39.9%) 180 (48.2%)
 UA 50 (3.0%) 19 (5.1%)
LVEF (%) 51.7 ± 11.2 48.9 ± 12.3 < 0.001
Heart rate (BPM) 75.5 ± 16.0 78.4 ± 15.7 0.001
Systolic BP (mmHg) 130.1 ± 23.5 131.9 ± 23.1 0.18
Diastolic BP (mmHg) 75.7 ± 14.5 75.4 ± 16.5 0.70
HDL-c (mmol/L) 1.2 ± 0.3 1.1 ± 0.3 < 0.001
LDL-c (mmol/L) 3.3 ± 1.1 2.7 ± 1.2 < 0.001
Triglycerides (mmol/L) 1.005 (0.66–1.53) 1.14 (0.81–1.83) < 0.001
Cholesterol (mmol/L) 5.0 ± 1.2 4.5 ± 1.4 < 0.001
Leukocytes (g/L) 9.7 (7.52–12.2) 9.34 (7.4–12.1) 0.197
CRP (mg/L) 2.5 (1.1–7) 3.9 (1.6–11.1) < 0.001
Glucose (mmol/L) 6.6 ± 1.9 9.8 ± 4.6 < 0.001
HBa1c (%) 5.8 ± 0.3 7.6 ± 1.9 < 0.001
hs troponin T (µg/L) 0.20 (0.06–0.71) 0.19 (0.057–0.681) 0.49
Creatine kinase (U/L) 235 (114–539) 185 (93–419) < 0.001
nt-probnp (ng/L) 337 (113–1155) 633 (192–2325) < 0.001
Cyr61 (pg/mL) 510 (340–951) 487 (344–780) 0.25
  1. BMI body mass index, CRP C-reactive protein, HBA1C haemoglobin A1c, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, LVEF left ventricular ejection fraction, STEMI ST segment elevation myocardial infarction, NSTEMI non ST-segment elevation myocardial infarction, UA unstable angina